What happens to basophils and tryptase, LXA₄ and CysLTs during aspirin desensitization?

References

• Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, Brockow K, Campo P, Celik G, Cernadas J, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013;68(10):1219–1232. doi:10.1111/all.12260.
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, Bousquet P, Celik G, Demoly P, Gomes ER, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011;66(7):818–829. doi:10.1111/j.1398-9995.2011.02557.x.
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002;89(5):474–478. doi:10.1016/S1081-1206(10)62084-4.
   PubMed Web of Science ®Google Scholar
• Badrani JH, Doherty TA. Cellular interactions in aspirin-exacerbated respiratory disease. Curr Opin Allergy Clin Immunol 2021;21(1):65–70. doi:10.1097/ACI.0000000000000712.
   PubMed Web of Science ®Google Scholar
• Rhyou HI, Nam YH, Park HS. Emerging biomarkers beyond leukotrienes for the management of nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease. Allergy Asthma Immunol Res 2022;14(2):153–167. doi:10.4168/aair.2022.14.2.153.
   PubMed Web of Science ®Google Scholar
• Higashi A, Kumlin M, Higashi N, Daham K, Gaber F, Lindeberg A, James A, Skedinger M, Delin I, Gyllfors P, et al. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma. Int Arch Allergy Immunol 2012;158(3):299–306. doi:10.1159/000331433.
   PubMed Web of Science ®Google Scholar
• Gaber F, Daham K, Higashi A, Higashi N, Gülich A, Delin I, James A, Skedinger M, Gyllfors P, Nord M, et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax 2008;63(12):1076–1082. doi:10.1136/thx.2008.101196.
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Celejewska-Wójcik N, Wójcik K, Gielicz A, Januszek R, Cholewa A, Stręk P, Sanak M. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity. Allergy 2014;69(11):1550–1559. doi:10.1111/all.12512.
   PubMed Web of Science ®Google Scholar
• Celik GE, Erkekol FO, Misirligil Z, Melli M. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin Exp Allergy 2007;37(10):1494–1501. doi:10.1111/j.1365-2222.2007.02806.x.
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R, DuBuske L. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol 2003;112(3):505–512. doi:10.1016/S0091-6749(03)01716-0.
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, Bonini M, Heffler E, Klimek L, Laidlaw TM, et al. Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper. Allergy 2019;74(1):28–39. doi:10.1111/all.13599.
   PubMed Web of Science ®Google Scholar
• Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. AD in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982;69(1 Pt 1):11–9. doi:10.1016/0091-6749(82)90081-1.
   Google Scholar
• Stevenson DD. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009;9(2):155–163. doi:10.1007/s11882-009-0023-4.
   PubMed Web of Science ®Google Scholar
• White AA, Stevenson DD. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med 2012;33(6):588–594. doi:10.1055/s-0032-1325618.
   PubMed Web of Science ®Google Scholar
• White AA, Stevenson DD. AD in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am 2013;33(2):211–222. doi:10.1016/j.iac.2012.10.013.
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. AD treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98(4):751–758. doi:10.1016/s0091-6749(96)70123-9.
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of AD treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003;90(3):338–341. doi:10.1016/S1081-1206(10)61803-0.
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with AD in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111(1):180–186. doi:10.1067/mai.2003.7.
   PubMed Web of Science ®Google Scholar
• Aydin Ö, Atmiş EÖ, Anadolu Y, Yorulmaz İ, Çelik GE. Aspirin desensitization following endoscopic sinus surgery is effective in patients with nonsteroidal antiinflammatory drug exacerbated respiratory disease. J Asthma 2022;1–10. doi:10.1080/02770903.2022.2134793.
   PubMed Web of Science ®Google Scholar
• Stevens WW, Jerschow E, Baptist AP, Borish L, Bosso JV, Buchheit KM, Cahill KN, Campo P, Cho SH, Keswani A, et al. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: a Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2021;147(3):827–844. doi:10.1016/j.jaci.2020.10.043.
   PubMed Web of Science ®Google Scholar
• Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, Simon RA, Wald J, Woessner KM, AD Joint Task Force. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007;98(2):172–174. doi:10.1016/S1081-1206(10)60692-8.
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention, Global Initiative for Asthma (GINA) 2018. Available from: https://ginasthma.org [last accessed 19 July 2022].
   Google Scholar
• Sanz ML, Gamboa P, de Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136(1):58–72. doi:10.1159/000082586.
   PubMed Web of Science ®Google Scholar
• Celik GE, Schroeder JT, Hamilton RG, Saini SS, Adkinson NF. Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy 2009;39(10):1522–1531. doi:10.1111/j.1365-2222.2009.03277.x.
   PubMed Web of Science ®Google Scholar
• Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Inhibition of monocyte leukotriene B4 production after AD. J Allergy Clin Immunol 1995;96(2):148–156. doi:10.1016/S0091-6749(95)70002-1.
   PubMed Web of Science ®Google Scholar
• Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347(19):1493–1499. doi:10.1056/NEJMoa013508.
   PubMed Web of Science ®Google Scholar
• May A, Weber A, Gall H, Kaufmann R, Zollner TM. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 1999;29(10):1402–1411. doi:10.1046/j.1365-2222.1999.00655.x.
   PubMed Web of Science ®Google Scholar
• Celik G, Bavbek S, Misirligil Z, Melli M. Release of cysteinyl leukotrienes with aspirin stimulation and effect of prostaglandin E2 on this release. Clin Exp Allergy 2001;31(10):1615–1622. doi:10.1046/j.1365-2222.2001.01074.x.
   PubMed Web of Science ®Google Scholar
• Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L, Serhan CN, Szczeklik A. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000;16(1):44–49. doi:10.1034/j.1399-3003.2000.16a08.x.
   PubMed Web of Science ®Google Scholar
• De Weck AL, Sanz ML, Gamboa PM, Jermann JM, Kowalski M, Medrala W, Sainte-Laudy J, Schneider MS, Weber JM, Wolanczyk-Medrala A, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. J Investig Allergol Clin Immunol 2010;20(1):39–57.
   PubMed Web of Science ®Google Scholar
• Korosec P, Mavsar N, Bajrovic N, Silar M, Mrhar A, Kosnik M. Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Int Arch Allergy Immunol 2011;155(3):257–262. doi:10.1159/000319846.
   PubMed Web of Science ®Google Scholar
• Abuaf N, Rostane H, Barbara J, Toly-Ndour C, Gaouar H, Mathelier-Fusade P, Leynadier F, Francès C, Girot R. Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity. J Allergy (Cairo) 2012;2012:580873. doi:10.1155/2012/580873.
   PubMedGoogle Scholar
• Stevens WW, Staudacher AG, Hulse KE, Poposki JA, Kato A, Carter RG, Suh LA, Norton JE, Huang JH, Peters AT, et al. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis. J Allergy Clin Immunol 2021;148(2):439–449.e5. doi:10.1016/j.jaci.2021.02.045.
   PubMed Web of Science ®Google Scholar
• Sehanobish E, Asad M, Jerschow E. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease. Curr Opin Allergy Clin Immunol. 2022;22(1):42–48. doi:10.1097/ACI.0000000000000795.
   PubMed Web of Science ®Google Scholar
• Xie H, Chen L, Zhang H, Wang J, Zang Y, Zhan M, Gu F, Wang S, He S. Increased expressions of CD123, CD63, CD203c, and Fc epsilon receptor I on blood leukocytes of allergic asthma. Front Mol Biosci 2022;9:907092.
   PubMed Web of Science ®Google Scholar
• Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol 2005;95(4):509–510.
   PubMed Web of Science ®Google Scholar
• Nasser SM, Patel M, Bell GS, Lee TH. The effect of AD on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care Med 1995;151(5):1326–1330. doi:10.1164/ajrccm.151.5.7735581.
   PubMed Web of Science ®Google Scholar
• Makowska JS, Olszewska-Ziąber A, Bieńkiewicz B, Lewandowska-Polak A, Kurowski M, Woźniakowski B, Rotkiewicz A, Kowalski ML. Clinical benefits of AD in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine. Allergy Asthma Proc 2016;37(3):216–224. doi:10.2500/aap.2016.37.3935.
   PubMed Web of Science ®Google Scholar
• Tyrak KE, Kupryś-Lipińska I, Czarnobilska E, Jakieła B, Pajdzik K, Ćmiel A, Plutecka H, Koziej M, Gawrońska A, Konduracka E, et al. Sputum biomarkers during AD in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease. Respir Med 2019;152:51–59. doi:10.1016/j.rmed.2019.04.021.
   PubMed Web of Science ®Google Scholar
• Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, Israel E, Boyce JA, Laidlaw TM. Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease. A prospective trial. Am J Respir Crit Care Med 2019;200(6):704–711. doi:10.1164/rccm.201809-1755OC.
   PubMed Web of Science ®Google Scholar
• Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res 2014;6(4):288–295. doi:10.4168/aair.2014.6.4.288.
   PubMed Web of Science ®Google Scholar
• Steinke JW, Culp JA, Kropf E, Borish L. Modulation by aspirin of nuclear phospho–signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with AD. J Allergy Clin Immunol 2009;124(4):724–730.e4. doi:10.1016/j.jaci.2009.07.031.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and proresolution. Prostaglandins Other Lipid Mediat 2002;68–69:433–455. doi:10.1016/s0090-6980(02)00047-3.
   PubMed Web of Science ®Google Scholar
• Aksu K, Kurt E, Alatas Ö, Gülbas Z. Effect of AD on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease. Allergy Asthma Proc 2014;35(2):148–155. doi:10.2500/aap.2014.35.3726.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Higashi N, Mita H, Ono E, Komase Y, Nakagawa T, Miyazawa T, Akiyama K, Taniguchi M. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 2011;41(12):1711–1718. doi:10.1111/j.1365-2222.2011.03839.x.
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Tyrak KE. Biomarkers for predicting response to long-term high dose aspirin therapy in aspirin-exacerbated respiratory disease. Clin Transl Allergy 2021;11(6):e12048.
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Celejewska-Wójcik N, Wójcik K, Gielicz A, Ćmiel A, Ignacak M, Oleś K, Szczeklik A, Sanak M. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma. Clin Exp Allergy 2015;45(12):1779–1789. doi:10.1111/cea.12654.
   PubMed Web of Science ®Google Scholar
• Celejewska-Wójcik N, Wójcik K, Ignacak-Popiel M, Ćmiel A, Tyrak K, Gielicz A, Kania A, Nastałek P, Sanak M, Mastalerz L. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis. Allergy 2020;75(4):831–840. doi:10.1111/all.14141.
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 2021;9(3):1133–1141. doi:10.1016/j.jaip.2020.09.063.
   PubMed Web of Science ®Google Scholar